Associated Press

After a dramatic helicopter return from the hospital where he was receiving an unprecedented level of care for COVID-19, Trump's attitude alarmed infectious disease experts.

The FDA said vaccine makers should follow trial participants for at least two months to rule out safety issues before seeking emergency approval.

President Trump's decision to return home from a military hospital despite his continued illness is putting new focus on the people around him who could be further exposed.

The fight over signatures is one of many partisan battles being fought in the state Legislature and the courts over mail-in voting in Pennsylvania.

Trump's expected return comes as the scale of the outbreak within the White House itself is still being uncovered.

“We know our pain is questioned and our pain is not real to them,” said Christy DeGallerie, who later started a group for Black COVID-19 survivors.

Trump has downplayed the severity and impact of the pandemic in recent months.

Activists have long called for the equipment to increase trust between police and civilians, but the program had been stalled over alleged funding concerns.

Hours earlier, Trump’s team reported that his blood oxygen level dropped suddenly twice recently and that they gave him a steroid typically recommended for the very sick.

Office of Defense Services Chief Defender Brendan O’Neill said a backlog of jury trials being scheduled will challenge the entire criminal justice system.

If they were in close contact with the president or his staff, they are being asked to quarantine for 14 days.

Toomey’s decision will force Pennsylvania Republicans to look elsewhere for nominees for both seats in a state where both parties have shown they can win statewide races.